DETERMINATION OF THE FREQUENCY OF OCCURRENCE OF THE MOST IMMUNOGENIC ERYTHROCYTE ANTIGENS IN PATIENTS USING THE ACROSS OCTO-M AUTOMATIC ANALYZER
Main Article Content
Abstract
Studying the frequency of occurrence of the most immunogenic red blood cell antigens in patients is important for understanding immune reactions and ensuring effective methods of transfusion therapy. Specific immunogenic antigens contained in red blood cells can cause the formation of antibodies in recipients, which can lead to various hemolytic reactions and other complications. The need for careful screening of donor red blood cells and an individual approach to transfusion therapy will minimize the risk of immune complications and improve the safety of treatment.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Gerritsma JJ, Oomen I, Meinderts S, van der Schoot CE, Biemond BJ, van der Bom JG, Fijnvandraat K; SCORE consortium. Back to base pairs: What is the genetic risk for red bloodcell alloimmunization? Blood Rev. 2021; 48: 100794. doi: 10.1016/j.blre.2020.100794
Shastry S, Chenna D, Basavarajegowda A, Das S, Chaudhary RK. Red blood cell alloimmunization among recipients of blood transfusion in India: A systematic review and meta-analysis. Vox Sang. 2022; 117(9): 1057-1069. doi: 10.1111/vox.13296
Badami KG, Neal C, Sparrow RL, Wellard C, Haysom HE, McQuilten ZK, Wood EM. Red blood cell alloantibodies in the context of critical bleeding and massive transfusion. Blood Transfus. 2023; 21(5): 390-399. doi: 10.2450/2022.0131-22
Li Q, Duan S, Sun A, Liao Y, Wu Y, Wang H, et al. Study on the antigens and antibodies of Mur and Mia blood groups in southern China. Transfus Apher Sci. 2022; 61(4): 103378. doi:10.1016/j.transci.2022.103378
Okello CD, Shih AW, Nabwana M, Kiwanuka N, Heddle N, Mayanja-Kizza H, Orem J. Frequency of red blood cell allo-immunization in patients undergoing blood transfusion at the Uganda Cancer Institute. Afr Health Sci. 2023; 23(4): 362-370. doi: 10.4314/ahs.v23i4.39
Wafford TR, Walker LP. Prevalence of Rh, Kell, Kidd, Duffy, and MNS antigens in the Hispanic donor population of South Texas. Immunohematology. 2022; 38(2): 43-50. doi:10.21307/immunohematology-2022-040
Matosinho CGR, Silva CGR, Martins ML, Silva-Malta MCF. Next Generation Sequencing of Red Blood Cell Antigens in Transfusion Medicine: Systematic Review and Meta-Analysis. Transfus Med Rev. 2024; 38(1): 150776. doi: 10.1016/j.tmrv.2023.150776
Salarvand S, Moeini Nasab S, Abdollahi A, Nozarian Z, Nazar E. Frequency and Underlying Causes of Alloimmunization Against Red Blood Cell Antigens in Patients Referred to the Blood Bank of the Tertiary Referral Hospital of Tehran from 2018 to 2020. Arch Iran Med. 2023; 26(9): 499-503. doi: 10.34172/aim.2023.75
Tamai Y, Ohto H, Takahashi H, Kitazawa J; Pediatric RBC Alloimmunization Consortium. Transfusion-Related Alloimmunization to Red Blood Cell Antigens in Japanese Pediatric Recipients. Transfus Med Rev. 2021; 35(1): 29-36. doi: 10.1016/j.tmrv.2020.09.001
Tordon B, Montemayor C, Clarke G, O'Brien SF, Goldman M. Use of selective phenotyping and genotyping to identify rare blood donors in Canada. Vox Sang. 2023; 118(5): 398-401. doi: 10.1111/vox.13419